West Pharmaceutical Services Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 61.3% | 61.9% | 66.7% | 67.1% | 64.5% | 63.3% | 66.7% | 64.3% | 63.5% | 62.2% | 64.9% | 62.3% | 63.2% | |
| 38.7% | 38.1% | 33.3% | 32.9% | 35.5% | 36.7% | 33.3% | 35.7% | 36.5% | 37.8% | 35.1% | 37.7% | 36.8% | |
| 2.2% | 2.5% | 2.5% | 2.5% | 2.1% | 2.5% | 2.3% | 2.5% | 2.1% | 2.7% | 1.9% | 2.3% | 2.2% | |
| 11.9% | 12.3% | 12.5% | 11.8% | 11.2% | 11.4% | 12.6% | 12.5% | 12.8% | 13.2% | 11.8% | 13.5% | 12.8% | |
| 13.2% | 14.8% | 15.0% | 14.3% | 13.0% | 13.9% | 14.9% | 15.0% | 14.9% | 18.2% | 14.1% | 17.2% | 16.1% | |
| 25.6% | 23.3% | 18.3% | 18.6% | 22.5% | 22.8% | 18.4% | 20.6% | 21.6% | 19.5% | 21.0% | 20.5% | 20.6% | |
| 0.4% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.7% | 0.2% | 0.3% | 0.3% | |
| 25.5% | 23.4% | 18.9% | 19.0% | 22.5% | 22.3% | 16.3% | 21.1% | 21.6% | 20.5% | 21.3% | 20.6% | 21.0% | |
| 3.9% | 4.7% | 2.4% | 3.1% | 4.3% | 4.9% | 3.5% | 3.9% | 4.2% | 4.1% | 5.3% | 3.7% | 4.3% | |
| 21.6% | 18.7% | 16.6% | 15.9% | 18.2% | 17.4% | 12.9% | 17.2% | 17.4% | 16.4% | 16.4% | 17.7% | 17.0% | |
| 30.2% | 28.0% | 23.7% | 24.1% | 27.5% | 27.5% | 21.6% | 25.9% | 27.0% | 26.0% | 25.9% | 20.5% | 24.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.